Celldex Therapeutics shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $470k | 11k | 41.97 |
| 2022-09-30 | $222k | 7.9k | 28.06 |
| 2022-06-30 | $337k | 13k | 26.96 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management